Issue 37, 2014

Capturing a novel metastable polymorph of the anticancer drug gefitinib

Abstract

Gefitinib, a life-extending anticancer drug, exhibits solvent-mediated conformational polymorphism to yield stable (form I) and novel metastable (form II) polymorphs. Crystal structure analysis revealed 3D isostructurality in the molecular organization of the polymorphs, and the metastable polymorph undergoes a crystal-to-crystal thermal phase transition to the stable polymorph.

Graphical abstract: Capturing a novel metastable polymorph of the anticancer drug gefitinib

Supplementary files

Article information

Article type
Communication
Submitted
12 Jul 2014
Accepted
22 Jul 2014
First published
08 Aug 2014

CrystEngComm, 2014,16, 8638-8641

Author version available

Capturing a novel metastable polymorph of the anticancer drug gefitinib

S. H. Thorat, M. V. Patwadkar, R. G. Gonnade and R. Vaidhyanathan, CrystEngComm, 2014, 16, 8638 DOI: 10.1039/C4CE01446D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements